Lawyer Seek Logo
Lawyer Seek Logo - Pargluva
Pargluva News

07/02/2007 - Accident Raises Safety Concerns About Chinese Tires

Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. Read more »

Regions of Practice:

New York
New Jersey
Nationwide
Martindale Hubbell Peer Review Rated Lawyer Logo

Martindale Hubbell AV Lawyer Logo

National Law Journal The Plaintiffs Hot List

Pargluva News

Email Pargluva Button
Print Pargluva Button
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. read more »

Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature read more »

What is Pargluva?


Pargluva, which has the generic name of muraglitazar, is sponsored by Bristol-Myers Squibb and Merck, and is a member of a new class of drugs known as dual PPAR-agonists. These are non-insulin drugs designed for type 2 diabetes patients in order to control their blood sugar and improve cholesterol levels by stimulating certain receptors in cells that are responsible for regulating fat and sugar. These drugs are aimed at reducing blood sugar levels while increasing levels of so called "good" cholesterol. Type 2 diabetes affects approximately 18 million people, and is the most widespread form of diabetes.


« Back to Pargluva page
Search Menu
Advanced Search
Topics
© 2008 Seeger Weiss LLP. All rights reserved. Statement of Clients' Rights: Please note that you are not considered our client unless you have signed a retainer agreement and your case has been accepted.Prior results do not guarantee or predict a similar outcome with respect to any future matter.1 William Street, New York, NY, 10004.